Developers

Developer Name Compounds Regimens Trials
Guangzhou Egg Biotechnology Co., Ltd.
(CNPQ) Conselho Nacional de Desenvolvimento Cientifíco e Tecnoloǵico
(FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulo
Anacor Pharmaceuticals
AstraZeneca
Bill & Melinda Gates Foundation
Boston University
Calibr, The Scripps Research Institute
CDC TBTC
CSIR-Institute for Microbial Technology (IMTech), Johnson & Johnson
EDCTP
German Center for Infection Research (DZIF)
GlaxoSmithKline
Hans-Knöll Institute, Jena
Harvard University Faculty of Medicine
iM4TB - Innovative Medicines for Tuberculosis
Institute of Materia Medica
Institute of Materia Medica, CAMS & PUMC
IUATLD, Inc.
Janssen Research & Development, LLC
LegoChem
LegoChem Biosciences, Inc.
Lilly TB Drug Discovery Initiative
Médecins Sans Frontières
Michigan State University
Microbiotix, Inc.
MicuRx Pharmaceuticals, Inc.
Nearmedic Plus LLC
NIAID, NIH, DHHS
Novartis
Otsuka Pharmaceutical Development & Commercialization, Inc.
PanACEA
Purdue University
Qurient Co. Ltd. / LLC "Infectex", a portfolio firm of Maxwell Biotech Venture Fund
Qurient Co., Ltd
Sanofi
São Paulo State University (UNESP)
Sequella, Inc
Spero Therapeutics, LLC
SPRINT TB (National University of Singapore)
St. George's Hospital University of London
TB Alliance
TB Drug Accelerator
The Aurum Institute NPC
University College, London
University of Auckland
University of Illinois at Chicago
University of Munich
USAID
Weill Medical College of Cornell University